松田豊（Yutaka Matsuda)-ADC Chemist-
Posting about antibody-drug conjugates (ADC), biopharma, and organic synthesis. I'm an ADC Chemistry Director in a U.S. pharma company, with a background in AJICAP and Exo-linker development, two Ph.D.s, and an MBA. Views are my own.
@viveksubbiah.bsky.social
Early Phase Drug Development; Oncologist; Precision Medicine; Phase 1 trials; AI & Precision Oncology; Clinical trials. Posts=My own
@elisabettabonzano.bsky.social
Radiation Oncologist, MD, PhD Fondazione IRCCS Policlinico San Matteo @UniPv - MIUR Qualified Associate Professor - PhD in Experimental Medicine
@kathryngarner.co.uk
Author-illustrator. Science Writer. I write an illustrated blog about Engineering Biology. Big topics are venom and drug discovery. https://kathryngarner.co.uk/blog
@oncoalert.bsky.social
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨 www.OncoAlert360.com
@chemrxiv.bsky.social
Community service not affiliated with ChemRxiv™ Admin: @yzimmermann.bsky.social
@ptarantinomd.bsky.social
Breast Medical Oncologist, Advanced Fellow Dana-Farber | Harvard | PhD Unimi. SoMe Editor ESMO Open. Interested in breast oncology, HER2, ADCs and good music.
@rcasainson.bsky.social
Excited about science, immunology, tumour microenvironment and new therapies.🇫🇷🇬🇧🇪🇺CSO of Advesya.🔬Cancer Research
@bsky.app
official Bluesky account (check username👆) Bugs, feature requests, feedback: support@bsky.app